Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 492: | Line 492: | ||
'''Diabetes Mellitus''' | '''Diabetes Mellitus''' | ||
* [[TREAT]] (2009): Darbepoetin in CKD and T2DM | * [[TREAT]] (2009): Darbepoetin in CKD and T2DM | ||
'''Hemorrhage''' | |||
* [[RE-VERSE AD]] (2015): Idarucizumab for dabigatran reversal | |||
'''Leukemia''' | '''Leukemia''' | ||
Line 511: | Line 514: | ||
* [[RE-COVER]] (2009): Dabigatran vs. warfarin in VTE | * [[RE-COVER]] (2009): Dabigatran vs. warfarin in VTE | ||
* [[WARFASA]] (2012): Aspirin after VTE treatment | * [[WARFASA]] (2012): Aspirin after VTE treatment | ||
'''Stroke''' | '''Stroke''' |